Epigral Ltd. (EPIGRAL) — Capital Reinvestment Ratio
Epigral Ltd. (EPIGRAL) has a Capital Reinvestment Ratio of 0.88x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs2.67 Billion) in capital expenditures (Rs2.36 Billion). Check how tangible is Epigral Ltd.'s equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Epigral Ltd. Capital Reinvestment Ratio (2015–2026)
This chart tracks Epigral Ltd.'s Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see EPIGRAL cash flow conversion.
Annual Capital Reinvestment Ratio for Epigral Ltd. (2015–2026)
Year-by-year Capital Reinvestment Ratio for Epigral Ltd. from 2015 to 2026. See EPIGRAL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 1.02x | Rs3.88 Billion | Rs3.94 Billion | ▲ +130.1% |
| 2025 | 0.44x | Rs4.41 Billion | Rs1.95 Billion | ▼ -55.9% |
| 2024 | 1.00x | Rs3.98 Billion | Rs3.98 Billion | ▲ +50.7% |
| 2023 | 0.67x | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.6% |
| 2022 | 1.61x | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.3% |
| 2021 | 0.86x | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs1.12 Billion | Rs34.48 Million | — |